Skip to main content
SpringerLink
Log in

Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

To investigate the immunoglobulin G (IgG) expression in prostate cancer cell lines and explore the effects of IGHG1 gene knockdown on PC3 cell growth and apoptosis. Flow cytometry, qPCR and western blot were used to demonstrate IgG expression in prostate cancer cell lines. PC3 cells were transfected with designed siRNA, the expression of IgG was determined by qPCR and western blot, the proliferation and apoptosis were detected by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenil)-2H-tetrazolium, inner salt (MTS) and flow cytometry. The percentages of IgG in LNCaP cell membrane and cytoplasm were 2.96 and 89.22 % by flow cytometer, those of PC3 cell were 86.73 and 90.99 % respectively. The average level of IgG1 mRNA expression in PC3 cell line was significantly higher than that in LNCaP cell line (3.08 ± 0.15 vs 1.00 ± 0.37, P = 0.001). The protein level of IgG expression of PC3 cell line was 1.92 ± 0.15, compared with LNCaP cell line (1.05 ± 0.86). The expression of IgG1 mRNA and protein level in transfected PC3 cells decreased, with significant statistical differences from the blank control group (P < 0.01). The PC3 cell growth inhibition rates were 31.3 and 43.3 % in 48 and 72 h respectively. The rate of apoptotic PC3 cells were 5.29 ± 0.41 % in experimental group higher than that in control group (1.49 ± 0.29 %) (P < 0.01). IgG was identified in prostate cancer cells, and the siRNA targeted silencing of IGHG1 can inhibit cell viability and promote apoptosis, which might therefore act as a potential target in prostate cancer gene therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics. CA Cancer J Clin 60:277–300. doi:10.3322/caac.200732

    Article  PubMed  Google Scholar 

  2. de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, Gravis G, Bodroqi I et al (2010) Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376:1147–1154. doi:10.1016/S0140-6736(10)61389-X

    Article  PubMed  Google Scholar 

  3. Qiu X, Zhu X, Zhang L, Mao Y, Zhang J, Hao P et al (2003) Human epithelial cancers secrete immunoglobulin G with unidentified specificity to promote growth and survival of tumor cells. Cancer Res 63:6488–6495

    PubMed  CAS  Google Scholar 

  4. Kimoto Y (1998) Expression of heavy-chain constant region of immunoglobulin and T-cell receptor gene transcripts in human non-hematopoietic tumor cell lines. Genes Chromosomes Cancer 22:83–86. doi:10.1002/(SICI)1098-2264

    Article  PubMed  CAS  Google Scholar 

  5. Chen Z, Gu J (2007) Immunoglobulin G expression in carcinomas and cancer cell lines. FASEB J 21:2931–2938. doi:10.1096/fj.07-8073com

    Article  PubMed  Google Scholar 

  6. Chen Z, Huang X, Ye J, Pan P, Cao Q, Yang B, Li Z, Su M, Huang C, Gu J (2010) Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades. Cancer 116:1953–1963. doi:10.1002/cncr.24892

    Article  PubMed  CAS  Google Scholar 

  7. Lee G, Chu RA, Ting HH (2009) Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody. Cancer Biol Ther 8:161–166. doi:10.4161/cbt.8.2.7117

    Article  PubMed  CAS  Google Scholar 

  8. Chen Z, Li J, Xiao Y, Zhang J, Zhao Y, Liu Y, Ma C, Qiu Y, Luo J, Huang G, Korteweg C, Gu J (2011) Immunoglobulin G locus events in soft tissue sarcoma cell lines. PLoS ONE 6:e21276. doi:10.1371/journal.pone.0021276

    Article  PubMed  CAS  Google Scholar 

  9. Hu D, Zheng H, Liu H, Li M, Ren W, Liao W, Duan Z, Li L, Cao Y (2008) Immunoglobulin expression and its biological significance in cancer cells. Cell Mol Immunol 5:319–324. doi:10.1038/cmi.2008.39

    Article  PubMed  CAS  Google Scholar 

  10. Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M et al (2004) Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis. Oligonucleotides 14:100–113. doi:10.1089/1545457041526290

    Article  PubMed  CAS  Google Scholar 

  11. Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, Scardino PT (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24:3973–3978. doi:10.1200/JCO.2005.04.0756

    Article  PubMed  CAS  Google Scholar 

  12. Babbage G, Ottensmeier CH, Blaydes J, Stevenson FK, Sahota SS (2006) Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res 66:3996–4000. doi:10.1158/0008-5472.CAN-05-3704

    Article  PubMed  CAS  Google Scholar 

  13. Zhang L, Hu S, Korteweg C, Chen Z, Qiu Y, Su M, Gu J (2012) Expression of immunoglobulin G in esophageal squamous cell carcinomas and its association with tumor grade and Ki67. Hum Pathol 43:423–434. doi:10.1016/j.humpath.2011.05.020

    Article  PubMed  CAS  Google Scholar 

  14. Zheng H, Li M, Liu H, Ren W, Hu DS, Shi Y, Tang M, Cao Y (2007) Immunoglobulin alpha heavy chain derived from human epithelial cancer cells promotes the access of S phase and growth of cancer cells. Cell Biol Int 31:82–87

    Article  PubMed  CAS  Google Scholar 

  15. Pan B, Zheng S, Xu Y, Liu C, Fang P (2012) Expression of IgG in prostate cancer and its clinical significances. J Pract Med 28:1312–1314. doi:10.3969/j.issn.1006-5725.2012.08.035

    Google Scholar 

  16. Qiu Y, Korteweg C, Chen Z, Li J, Luo J, Huang G, Gu J (2012) Immunoglobulin G expression and its colocalization with complement proteins in papillary thyroid cancer. Mod Pathol 25:36–45. doi:10.1038/modpathol.2011.139

    Article  PubMed  CAS  Google Scholar 

  17. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA (2002) RNA interference in adult mice. Nature 418:38–39. doi:10.1038/418038a

    Article  PubMed  CAS  Google Scholar 

  18. Wilda M, Fuchs U, Wossmann W, Borkhardt A (2002) Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 21:5124–5716. doi:10.1038/sj.onc.1205653

    Article  Google Scholar 

  19. Yang SB, Chen X, Wu BY, Wang MW, Cai CH, Cho DB et al (2009) Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue. Scand J Gastroenterol 44:1443–1451. doi:10.3109/00365520903369953

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, The First Affiliated Hospital, Jinan University, Guangzhou, People’s Republic of China

    Bin Pan

  2. Department of Urology, Zhujiang Hospital of Southern Medical University, No. 253, Industrial Road, Guang Zhou, 510280, Guang Dong, People’s Republic of China

    Shaobo Zheng, Chunxiao Liu & Yawen Xu

Authors
  1. Bin Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shaobo Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chunxiao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yawen Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shaobo Zheng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pan, B., Zheng, S., Liu, C. et al. Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell. Mol Biol Rep 40, 27–33 (2013). https://doi.org/10.1007/s11033-012-1944-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1944-x

Keywords

Search

Navigation